📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Trigyn Technologies Chairman Dr. Satyam Cherukuri Resigns Effective April 7, 2026
Dr. Satyam Cherukuri has tendered his resignation as the Chairman and Non-Executive Director of Trigyn Technologies, effective April 7, 2026. He will also step down from the board of the company's subsidiary, Trigyn Technologies Inc., on the same date. The resignation is attributed to personal circumstances that require his full attention. The company has approximately one month to manage the leadership transition before the effective date.
Key Highlights
Dr. Satyam Cherukuri (DIN: 01294234) to step down as Chairman and Non-Executive Director effective April 7, 2026
Resignation also applies to his role as a Board Member of the subsidiary Trigyn Technologies Inc.
The exit is cited as being due to personal circumstances requiring full commitment
The outgoing Chairman has committed to a smooth transition period until the effective date
💼 Action for Investors
Investors should monitor the board's next steps regarding the appointment of a successor to the Chairman position. While the resignation appears orderly, leadership changes at the board level can impact long-term strategic direction.
Trigyn Tech Q3 Revenue Grows 25% to ₹258 Cr; Net Profit Declines to ₹69 Lakhs
Trigyn Technologies reported a 24.8% YoY increase in revenue from operations to ₹25,803.19 lakhs for Q3 FY26. However, net profit for the quarter saw a sharp decline to ₹69.12 lakhs from ₹123.48 lakhs in the previous year, impacted by higher other expenses and exceptional items. The company's 9-month FY26 net profit stands at ₹135.45 lakhs, significantly lower than the ₹921.16 lakhs reported in the same period last year. Notably, the company has deferred recognition of ₹80 crores in revenue due to collection uncertainties, and faces a GST demand of ₹9.08 crores.
Key Highlights
Revenue from operations increased by 24.8% YoY to ₹25,803.19 lakhs in Q3 FY26.
Net profit for the quarter dropped to ₹69.12 lakhs from ₹123.48 lakhs in Q3 FY25.
Deferred recognition of ₹80 crores in guaranteed revenue based on independent expert opinion regarding collection uncertainty.
Facing a GST show cause notice of ₹9.08 crores for the period FY 2019-20 to FY 2022-23.
Exceptional items of ₹179.63 lakhs impacted the bottom line during the current quarter.
💼 Action for Investors
Investors should exercise caution as the strong top-line growth is not translating into bottom-line profits due to high operational costs and legal contingencies. Closely monitor the resolution of the ₹80 crore revenue recognition dispute and the Nashik parking project arbitration.
Trigyn Technologies Q3 Revenue Grows 6.6% QoQ, but Consolidated PAT Plummets 87%
Trigyn Technologies reported a consolidated revenue of Rs. 25,803.19 Lakhs for Q3 FY26, a sequential growth of 6.6% from the previous quarter. However, the consolidated Profit After Tax (PAT) saw a sharp decline to Rs. 69.12 Lakhs from Rs. 527.21 Lakhs in Q2. For the nine-month period, while revenue grew by 10.2% YoY to Rs. 72,448.30 Lakhs, PAT dropped significantly from Rs. 921.16 Lakhs to Rs. 135.45 Lakhs. The standalone business showed signs of recovery in Q3 with a profit of Rs. 132.93 Lakhs compared to a loss in the previous quarter.
Key Highlights
Consolidated Q3 revenue increased to Rs. 25,803.19 Lakhs from Rs. 24,195.14 Lakhs in Q2.
Consolidated Q3 PAT fell sharply to Rs. 69.12 Lakhs, down 86.9% from Rs. 527.21 Lakhs in the previous quarter.
Nine-month consolidated PAT dropped to Rs. 135.45 Lakhs from Rs. 921.16 Lakhs in the previous year.
Standalone nine-month performance resulted in a loss of Rs. 518.09 Lakhs compared to a profit of Rs. 68.27 Lakhs YoY.
Standalone Q3 revenue grew to Rs. 6,279.23 Lakhs with a turnaround profit of Rs. 132.93 Lakhs.
💼 Action for Investors
Investors should exercise caution as the significant drop in consolidated net profit suggests severe margin pressure despite steady revenue growth. It is critical to monitor management's explanation for the rising costs that eroded the bottom line.
Trigyn Tech Q3 Revenue Rises 25% to ₹258 Cr; Net Profit Drops to ₹0.69 Cr Amid Legal Headwinds
Trigyn Technologies reported a strong 24.8% YoY growth in consolidated revenue to ₹25,803.19 lakhs for Q3 FY26. However, net profit declined to ₹69.12 lakhs from ₹123.48 lakhs in the year-ago period, impacted by an exceptional item of ₹179.63 lakhs and rising operational costs. The company's 9-month net profit shows a sharp decline to ₹135.45 lakhs compared to ₹921.16 lakhs in the previous year. Significant concerns remain regarding a deferred revenue recognition of ₹80 crores due to collection uncertainty and a ₹9.08 crore GST show-cause notice.
Key Highlights
Consolidated revenue from operations grew 24.8% YoY to ₹25,803.19 lakhs.
Net profit for the quarter fell to ₹69.12 lakhs, down from ₹123.48 lakhs in Q3 FY25.
Management deferred recognition of ₹80 crores in guaranteed revenue due to low probability of collection.
Facing a GST show-cause notice of ₹9.08 crores regarding disputed Input Tax Credit for FY 2019-23.
Total Comprehensive Income improved to ₹964.39 lakhs, primarily driven by currency translation gains of ₹682.57 lakhs.
💼 Action for Investors
Investors should exercise caution as core profitability is weakening despite revenue growth. Closely monitor the resolution of the ₹80 crore deferred revenue and the Nashik parking project arbitration, as these could significantly impact future valuations.